Nicotine replacement doesn't increase cardio risk after ACS

September 17, 2012
Nicotine replacement doesn't increase cardio risk after ACS
Use of nicotine replacement therapy does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes, according to research published in the Oct. 1 issue of The American Journal of Cardiology.

(HealthDay)—Use of nicotine replacement therapy (NRT) does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes (ACS), according to research published in the Oct. 1 issue of The American Journal of Cardiology.

Kevin J. Woolf, M.D., of the University of Rochester Medical Center in New York, and colleagues conducted a study involving 663 smokers with ACS, identified from a pre-existing database, who were separated into NRT (184 participants) or control (479 participants) groups based on whether they had been prescribed NRT on hospital discharge.

Of the cohort, 202 had adverse events into the first year following ACS. The researchers observed no significant difference between the groups for the one-year combined end point of death; myocardial infarction; repeat revascularization; or rehospitalization for angina, , or arrhythmia. In addition, no significant difference was found between the groups at one-year for each individual end point.

"The results of the present study suggest that NRT use after ACS was not associated with an increased risk of adverse cardiovascular events," the authors write. "These results might be particularly important in the treatment of smokers with , because the use of medication to stop smoking roughly doubles the success rates in long-term abstinence by reducing withdrawal symptoms."

Explore further: Prasugrel versus clopidogrel for ACS patients managed without revascularisation

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Prasugrel versus clopidogrel for ACS patients managed without revascularisation

August 27, 2012
The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the ...

Nicotine replacement therapies may not be effective in helping people quit smoking, study says

January 9, 2012
Nicotine replacement therapies (NRTs) designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking ...

Global platelet reactivity and high risk ACS patients

August 28, 2012
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at ESC Congress 2012.

Recommended for you

Cholesterol crystals are sure sign a heart attack may loom

August 17, 2017
A new Michigan State University study on 240 emergency room patients shows just how much of a role a person's cholesterol plays, when in a crystallized state, during a heart attack.

How Gata4 helps mend a broken heart

August 15, 2017
During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts ...

Injectable tissue patch could help repair damaged organs

August 14, 2017
A team of U of T Engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.

'Fat but fit' are at increased risk of heart disease

August 14, 2017
Carrying extra weight could raise your risk of heart attack by more than a quarter, even if you are otherwise healthy.

Air pollution linked to cardiovascular disease; air purifiers may lessen impact

August 14, 2017
Exposure to high levels of air pollution increased stress hormone levels and negative metabolic changes in otherwise healthy, young adults in a recent study conducted in China. Air purifiers appeared to lessen the negative ...

Study hints at experimental therapy for heart fibrosis

August 14, 2017
Researchers report encouraging preclinical results as they pursue elusive therapeutic strategies to repair scarred and poorly functioning heart tissues after cardiac injury—describing an experimental molecular treatment ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.